Psychedelics were once the domain of hippies and cults, but these drugs have come long way from the ‘turn on, tune in, drop out’ countercultural philosophy of the 1960s and 70s. Nowadays, the field of psychedelic research is experiencing a resurgence, with substances like psilocybin, MDMA and ketamine being used in controlled laboratories to treat complex mental health issues. In 2023, Australia became the first country in the world to permit psychiatrists to use psychedelic medicines to treat certain patients. But are psychedelic assisted therapies a silver bullet cure for mental health disorders, or have the regulations gotten ahead of the evidence?